COVCleo DiagnosticsCOV info
$0.27info-2.44%24h
Global rank27234
Market cap$34.77M
Change 7d2.56%
YTD Performance128.57%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings-$1.17M
Dividend yield-

Cleo Diagnostics (COV) Stock Overview

Cleo Diagnostics Ltd, a medical diagnostics and devices company, focuses on the development of non-invasive blood based IVD tests to detect the presence and recurrence of ovarian cancer in Australia. It focuses on the development of triage, recurrence, and screening tests for ovarian cancer detection. The company was incorporated in 2021 and is based in Melbourne, Australia.

COV Stock Information

Symbol
COV
Address
480 Collins StreetMelbourne, VIC 3000Australia
Founded
-
Trading hours
10:00 AM - 4:00 PM AEST
Website
https://www.cleodx.com
Country
🇦🇺 Australia
Phone Number
61 3 9614 0600

Cleo Diagnostics (COV) Price Chart

-
Value:-

Cleo Diagnostics Overview: Key Details and Summary

Stock data
2023
Change
Price
$0.27061402321868316
N/A
Market Cap
$34.77M
N/A
Shares Outstanding
128.50M
N/A
Employees
0
N/A
Earnings
2023
Change
Earnings
-$1.17M
N/A
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org